Previous 10 | Next 10 |
TYMLOS ® Q3, 2021 net revenue: $57 million, +13% vs. Q3, 2020 Added 4,461 new patients on TYMLOS in Q3, 2021, +10% vs. Q3, 2020 Adjusted EBITDA of ($11) million vs. $9 million in Q3, 2020 which included elacestrant license revenue ATOM Pivotal Study evaluating abalopa...
Radius Health (NASDAQ:RDUS) is scheduled to announce Q3 earnings results on Monday, November 8th, before market open. The consensus EPS Estimate is -$0.08 (-153.3% Y/Y) and the consensus Revenue Estimate is $61.27M (-21.3% Y/Y). Over the last 2 years, RDUS has beaten EPS estimates 38% of the ...
AVDL, AXSM, BKI, COTY, CTRE, DS,EDIT, EHTH, IMOS, KOS, LINC, LTBR, MTNB, NERV, OCN, PSEC, RDUS, RETA, TGLS, THS, TSEM, TTD, TYME, USFD, VAC, VTRS, WOW For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
BOSTON, Oct. 21, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline yesterday, Oct. 20, by Radius Health, Inc. (NASDAQ: RDUS), please note that the dial-in numbers were listed incorrectly. The correct dial-in numbers are (866) 323-7965 for domestic calls and (346) 406-0961...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Radius Health, Inc. and Menarini Group Announce Positive Phase 3 Topline Results from the EMERALD Study ” Radius Health, Inc. (NASDAQ: RDUS) surged ove...
BOSTON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ: RDUS) announced today that it will release its third quarter financial results on Monday, November 8, 2021. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provid...
Verizon (NYSE:VZ) posted an advance in Wednesday's midday trading, boosted by strong quarterly earnings and increased guidance. Pinterest (NYSE:PINS) was another high-profile winner in the intraday period, bolstered by reports that PayPal (NASDAQ:PYPL) was considering an offer for the company...
Shares of Radius Health (NASDAQ: RDUS) , a biopharmaceutical company, are soaring today in response to positive clinical-trial data. Investors excited about elacestrant, an experimental new cancer treatment Radius Health is developing in partnership with the Menarini Group, an Itali...
Shares of Olema Pharmaceuticals (OLMA +15.6%) are up significantly this morning after Jefferies issued a buy recommendation and a $55 price target (~105% return). Analyst Michael Yee says that the company could benefit from Radius Health's (RDUS +30.0%) late-stage results on breast cancer can...
Gainers: Sesen Bio (NASDAQ:SESN) +43%, Radius Health (NASDAQ:RDUS) +29%, Valneva SE (NASDAQ:VALN) +15%, Olema Pharmaceuticals (NASDAQ:OLMA) +15%, First Wave BioPharma (NASDAQ:FWBI) +6%. Losers: ATI Physical Therapy (NYSE:ATIP) -20%, HCW Biologics (...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...